← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Isotherapeutics Group, Llc
Angleton, TX
$3,043,137
Total funding
4
Grants
Funding over time
peak $1.3M · FY2010–15$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,634,379 · 2
DOE$1,408,758 · 2
By mechanism
R44$1,490,797 · 1
—$1,408,758 · 2
R43$143,582 · 1
Investigators at Isotherapeutics Group, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
SBIR-PHASE I NEW; HIGH SPECIFIC ACTIVITY SM-153 BY POST IRRADIATION ISOTOPE SEPARATION; JAIME SIMON$1,259,061
· FY2012 · Department of Energy
A new radiopharmaceutical for the treatment of metastatic bone cancer$701,849
R44 · FY2014 · CA
A new radiopharmaceutical for the treatment of metastatic bone cancer$694,709
R44 · FY2013 · CA
HIGH SPECIFIC ACTIVITY SN-117M BY POST IRRADIATION ISOTOPE SEPARATION$149,697
· FY2014 · Department of Energy
A new radiopharmaceutical for the treatment of metastatic bone cancer$143,582
R43 · FY2010 · CA
A new radiopharmaceutical for the treatment of metastatic bone cancer$94,239
R44 · FY2015 · CA